nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Carmustine—malignant glioma	0.122	0.57	CbGbCtD
Doxepin—CYP3A4—Temozolomide—malignant glioma	0.0923	0.431	CbGbCtD
Doxepin—HTR2C—choroid plexus—malignant glioma	0.0284	0.12	CbGeAlD
Doxepin—HTR2A—choroid plexus—malignant glioma	0.0143	0.06	CbGeAlD
Doxepin—ORM1—vertebral column—malignant glioma	0.0112	0.047	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—malignant glioma	0.00833	0.035	CbGeAlD
Doxepin—HTR2A—cerebellar cortex—malignant glioma	0.00718	0.0302	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—malignant glioma	0.00701	0.0295	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—malignant glioma	0.00633	0.0267	CbGeAlD
Doxepin—HTR2A—pons—malignant glioma	0.00508	0.0214	CbGeAlD
Doxepin—HTR2A—vertebral column—malignant glioma	0.00504	0.0212	CbGeAlD
Doxepin—Transaminases increased—Carmustine—malignant glioma	0.00473	0.0183	CcSEcCtD
Doxepin—Cerebration impaired—Temozolomide—malignant glioma	0.00473	0.0183	CcSEcCtD
Doxepin—Cyst—Carmustine—malignant glioma	0.00431	0.0167	CcSEcCtD
Doxepin—HTR2A—telencephalic ventricle—malignant glioma	0.00418	0.0176	CbGeAlD
Doxepin—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00369	0.0143	CcSEcCtD
Doxepin—Herpes zoster—Temozolomide—malignant glioma	0.00369	0.0143	CcSEcCtD
Doxepin—HTR2A—pineal body—malignant glioma	0.00362	0.0153	CbGeAlD
Doxepin—HTR6—telencephalon—malignant glioma	0.00346	0.0146	CbGeAlD
Doxepin—Petechiae—Temozolomide—malignant glioma	0.00338	0.0131	CcSEcCtD
Doxepin—Disturbance in attention—Temozolomide—malignant glioma	0.00321	0.0124	CcSEcCtD
Doxepin—Thinking abnormal—Carmustine—malignant glioma	0.00314	0.0122	CcSEcCtD
Doxepin—Viral infection—Temozolomide—malignant glioma	0.00308	0.0119	CcSEcCtD
Doxepin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00306	0.0119	CcSEcCtD
Doxepin—Gait disturbance—Carmustine—malignant glioma	0.00295	0.0114	CcSEcCtD
Doxepin—Hearing impaired—Temozolomide—malignant glioma	0.00292	0.0113	CcSEcCtD
Doxepin—Neck pain—Carmustine—malignant glioma	0.00291	0.0113	CcSEcCtD
Doxepin—Gait disturbance—Temozolomide—malignant glioma	0.00285	0.011	CcSEcCtD
Doxepin—ADRA1D—telencephalon—malignant glioma	0.0027	0.0114	CbGeAlD
Doxepin—Neoplasm—Carmustine—malignant glioma	0.0026	0.0101	CcSEcCtD
Doxepin—Gynaecomastia—Carmustine—malignant glioma	0.00258	0.00998	CcSEcCtD
Doxepin—Neoplasm—Temozolomide—malignant glioma	0.00252	0.00974	CcSEcCtD
Doxepin—Mental disability—Carmustine—malignant glioma	0.0025	0.00968	CcSEcCtD
Doxepin—Mental disability—Temozolomide—malignant glioma	0.00241	0.00935	CcSEcCtD
Doxepin—Ear pain—Temozolomide—malignant glioma	0.00237	0.00917	CcSEcCtD
Doxepin—Eye pain—Carmustine—malignant glioma	0.00231	0.00897	CcSEcCtD
Doxepin—Gastroenteritis—Temozolomide—malignant glioma	0.00228	0.00883	CcSEcCtD
Doxepin—Deafness—Temozolomide—malignant glioma	0.00226	0.00874	CcSEcCtD
Doxepin—Vascular purpura—Temozolomide—malignant glioma	0.00226	0.00874	CcSEcCtD
Doxepin—HTR2C—brainstem—malignant glioma	0.00225	0.00948	CbGeAlD
Doxepin—HTR2A—endothelium—malignant glioma	0.00224	0.00944	CbGeAlD
Doxepin—Eye pain—Temozolomide—malignant glioma	0.00224	0.00867	CcSEcCtD
Doxepin—Nasal congestion—Temozolomide—malignant glioma	0.00222	0.00859	CcSEcCtD
Doxepin—CHRM4—central nervous system—malignant glioma	0.0022	0.00925	CbGeAlD
Doxepin—Hot flush—Temozolomide—malignant glioma	0.00216	0.00836	CcSEcCtD
Doxepin—Menopausal symptoms—Temozolomide—malignant glioma	0.00214	0.00829	CcSEcCtD
Doxepin—SLC6A4—brainstem—malignant glioma	0.00214	0.00899	CbGeAlD
Doxepin—Purpura—Temozolomide—malignant glioma	0.0021	0.00812	CcSEcCtD
Doxepin—Diplopia—Carmustine—malignant glioma	0.00209	0.0081	CcSEcCtD
Doxepin—CHRM2—telencephalon—malignant glioma	0.00207	0.00873	CbGeAlD
Doxepin—HTR2A—blood vessel—malignant glioma	0.00207	0.0087	CbGeAlD
Doxepin—Diplopia—Temozolomide—malignant glioma	0.00202	0.00782	CcSEcCtD
Doxepin—HTR2C—telencephalon—malignant glioma	0.002	0.00842	CbGeAlD
Doxepin—Amitriptyline—NTRK2—malignant glioma	0.00197	0.151	CrCbGaD
Doxepin—HTR6—central nervous system—malignant glioma	0.00197	0.00828	CbGeAlD
Doxepin—Ataxia—Carmustine—malignant glioma	0.00196	0.00761	CcSEcCtD
Doxepin—Hypokalaemia—Carmustine—malignant glioma	0.0019	0.00737	CcSEcCtD
Doxepin—Ataxia—Temozolomide—malignant glioma	0.0019	0.00736	CcSEcCtD
Doxepin—HTR1A—brainstem—malignant glioma	0.0019	0.00798	CbGeAlD
Doxepin—SLC6A4—telencephalon—malignant glioma	0.0019	0.00798	CbGeAlD
Doxepin—CHRM1—telencephalon—malignant glioma	0.00189	0.00795	CbGeAlD
Doxepin—SLC6A2—brainstem—malignant glioma	0.00188	0.00791	CbGeAlD
Doxepin—HTR2B—telencephalon—malignant glioma	0.00188	0.00791	CbGeAlD
Doxepin—Hypokalaemia—Temozolomide—malignant glioma	0.00184	0.00712	CcSEcCtD
Doxepin—Breast disorder—Temozolomide—malignant glioma	0.00182	0.00707	CcSEcCtD
Doxepin—HRH2—central nervous system—malignant glioma	0.0018	0.00757	CbGeAlD
Doxepin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00178	0.0069	CcSEcCtD
Doxepin—ADRA1A—brainstem—malignant glioma	0.00175	0.00736	CbGeAlD
Doxepin—CHRM4—brain—malignant glioma	0.00174	0.00734	CbGeAlD
Doxepin—CHRM5—central nervous system—malignant glioma	0.00172	0.00723	CbGeAlD
Doxepin—Pancytopenia—Carmustine—malignant glioma	0.00172	0.00664	CcSEcCtD
Doxepin—DRD2—brainstem—malignant glioma	0.00171	0.00721	CbGeAlD
Doxepin—CHRM3—telencephalon—malignant glioma	0.00169	0.00711	CbGeAlD
Doxepin—HTR1A—telencephalon—malignant glioma	0.00168	0.00708	CbGeAlD
Doxepin—Bronchitis—Temozolomide—malignant glioma	0.00168	0.0065	CcSEcCtD
Doxepin—SLC6A2—telencephalon—malignant glioma	0.00167	0.00702	CbGeAlD
Doxepin—Pancytopenia—Temozolomide—malignant glioma	0.00166	0.00642	CcSEcCtD
Doxepin—DRD2—retina—malignant glioma	0.00165	0.00696	CbGeAlD
Doxepin—Dysuria—Temozolomide—malignant glioma	0.00163	0.00632	CcSEcCtD
Doxepin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00162	0.00628	CcSEcCtD
Doxepin—Pneumonia—Carmustine—malignant glioma	0.00162	0.00627	CcSEcCtD
Doxepin—Pollakiuria—Temozolomide—malignant glioma	0.00161	0.00625	CcSEcCtD
Doxepin—Erectile dysfunction—Temozolomide—malignant glioma	0.00161	0.00623	CcSEcCtD
Doxepin—Weight increased—Temozolomide—malignant glioma	0.00159	0.00615	CcSEcCtD
Doxepin—Neuropathy peripheral—Carmustine—malignant glioma	0.00158	0.00611	CcSEcCtD
Doxepin—HTR2C—medulla oblongata—malignant glioma	0.00157	0.00661	CbGeAlD
Doxepin—Stomatitis—Carmustine—malignant glioma	0.00157	0.00608	CcSEcCtD
Doxepin—ADRA1B—central nervous system—malignant glioma	0.00157	0.00661	CbGeAlD
Doxepin—Urinary tract infection—Carmustine—malignant glioma	0.00157	0.00606	CcSEcCtD
Doxepin—Pneumonia—Temozolomide—malignant glioma	0.00157	0.00606	CcSEcCtD
Doxepin—HTR6—brain—malignant glioma	0.00156	0.00657	CbGeAlD
Doxepin—ORM1—spinal cord—malignant glioma	0.00156	0.00656	CbGeAlD
Doxepin—Infestation—Temozolomide—malignant glioma	0.00156	0.00603	CcSEcCtD
Doxepin—Infestation NOS—Temozolomide—malignant glioma	0.00156	0.00603	CcSEcCtD
Doxepin—ADRA1A—telencephalon—malignant glioma	0.00155	0.00653	CbGeAlD
Doxepin—ADRA1D—central nervous system—malignant glioma	0.00154	0.00646	CbGeAlD
Doxepin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00153	0.00591	CcSEcCtD
Doxepin—DRD2—telencephalon—malignant glioma	0.00152	0.0064	CbGeAlD
Doxepin—Stomatitis—Temozolomide—malignant glioma	0.00152	0.00588	CcSEcCtD
Doxepin—Urinary tract infection—Temozolomide—malignant glioma	0.00151	0.00586	CcSEcCtD
Doxepin—KCNH2—telencephalon—malignant glioma	0.0015	0.00631	CbGeAlD
Doxepin—ADRA2C—telencephalon—malignant glioma	0.00148	0.00622	CbGeAlD
Doxepin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00147	0.0057	CcSEcCtD
Doxepin—Sinusitis—Temozolomide—malignant glioma	0.00146	0.00566	CcSEcCtD
Doxepin—Hypoaesthesia—Carmustine—malignant glioma	0.00144	0.00557	CcSEcCtD
Doxepin—Hallucination—Carmustine—malignant glioma	0.00144	0.00557	CcSEcCtD
Doxepin—HTR2C—midbrain—malignant glioma	0.00144	0.00604	CbGeAlD
Doxepin—HRH2—brain—malignant glioma	0.00143	0.00601	CbGeAlD
Doxepin—Oedema peripheral—Carmustine—malignant glioma	0.00142	0.00552	CcSEcCtD
Doxepin—Connective tissue disorder—Carmustine—malignant glioma	0.00142	0.0055	CcSEcCtD
Doxepin—HTR2C—spinal cord—malignant glioma	0.0014	0.0059	CbGeAlD
Doxepin—Hepatitis—Temozolomide—malignant glioma	0.0014	0.00541	CcSEcCtD
Doxepin—Hallucination—Temozolomide—malignant glioma	0.00139	0.00538	CcSEcCtD
Doxepin—Hypoaesthesia—Temozolomide—malignant glioma	0.00139	0.00538	CcSEcCtD
Doxepin—Pharyngitis—Temozolomide—malignant glioma	0.00139	0.00537	CcSEcCtD
Doxepin—Urinary tract disorder—Temozolomide—malignant glioma	0.00138	0.00534	CcSEcCtD
Doxepin—Oedema peripheral—Temozolomide—malignant glioma	0.00138	0.00533	CcSEcCtD
Doxepin—Connective tissue disorder—Temozolomide—malignant glioma	0.00137	0.00532	CcSEcCtD
Doxepin—Urethral disorder—Temozolomide—malignant glioma	0.00137	0.00531	CcSEcCtD
Doxepin—CHRM5—brain—malignant glioma	0.00136	0.00574	CbGeAlD
Doxepin—SLC6A4—midbrain—malignant glioma	0.00136	0.00573	CbGeAlD
Doxepin—ABCB1—blood vessel—malignant glioma	0.00135	0.0057	CbGeAlD
Doxepin—Eye disorder—Carmustine—malignant glioma	0.00135	0.00523	CcSEcCtD
Doxepin—Flushing—Carmustine—malignant glioma	0.00134	0.0052	CcSEcCtD
Doxepin—SLC6A4—spinal cord—malignant glioma	0.00133	0.00559	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—malignant glioma	0.00131	0.00552	CbGeAlD
Doxepin—Eye disorder—Temozolomide—malignant glioma	0.00131	0.00506	CcSEcCtD
Doxepin—Tinnitus—Temozolomide—malignant glioma	0.0013	0.00505	CcSEcCtD
Doxepin—Cardiac disorder—Temozolomide—malignant glioma	0.0013	0.00502	CcSEcCtD
Doxepin—Flushing—Temozolomide—malignant glioma	0.0013	0.00502	CcSEcCtD
Doxepin—Arrhythmia—Carmustine—malignant glioma	0.00129	0.005	CcSEcCtD
Doxepin—Alopecia—Carmustine—malignant glioma	0.00128	0.00495	CcSEcCtD
Doxepin—Angiopathy—Temozolomide—malignant glioma	0.00127	0.00491	CcSEcCtD
Doxepin—Mental disorder—Carmustine—malignant glioma	0.00127	0.00491	CcSEcCtD
Doxepin—ORM1—central nervous system—malignant glioma	0.00126	0.00532	CbGeAlD
Doxepin—Immune system disorder—Temozolomide—malignant glioma	0.00126	0.00489	CcSEcCtD
Doxepin—Mediastinal disorder—Temozolomide—malignant glioma	0.00126	0.00488	CcSEcCtD
Doxepin—Erythema—Carmustine—malignant glioma	0.00126	0.00488	CcSEcCtD
Doxepin—Malnutrition—Carmustine—malignant glioma	0.00126	0.00488	CcSEcCtD
Doxepin—Chills—Temozolomide—malignant glioma	0.00125	0.00486	CcSEcCtD
Doxepin—ADRA1B—brain—malignant glioma	0.00125	0.00524	CbGeAlD
Doxepin—Alopecia—Temozolomide—malignant glioma	0.00123	0.00478	CcSEcCtD
Doxepin—HTR2A—embryo—malignant glioma	0.00123	0.00519	CbGeAlD
Doxepin—Mental disorder—Temozolomide—malignant glioma	0.00122	0.00474	CcSEcCtD
Doxepin—ADRA1D—brain—malignant glioma	0.00122	0.00513	CbGeAlD
Doxepin—Amitriptyline—NTRK1—malignant glioma	0.00122	0.0935	CrCbGaD
Doxepin—Back pain—Carmustine—malignant glioma	0.00122	0.00472	CcSEcCtD
Doxepin—Erythema—Temozolomide—malignant glioma	0.00122	0.00471	CcSEcCtD
Doxepin—Malnutrition—Temozolomide—malignant glioma	0.00122	0.00471	CcSEcCtD
Doxepin—HTR1A—midbrain—malignant glioma	0.00121	0.00509	CbGeAlD
Doxepin—HRH1—telencephalon—malignant glioma	0.0012	0.00505	CbGeAlD
Doxepin—Dysgeusia—Temozolomide—malignant glioma	0.00119	0.00461	CcSEcCtD
Doxepin—Vision blurred—Carmustine—malignant glioma	0.00119	0.00459	CcSEcCtD
Doxepin—ADRA2A—telencephalon—malignant glioma	0.00118	0.00496	CbGeAlD
Doxepin—HTR1A—spinal cord—malignant glioma	0.00118	0.00496	CbGeAlD
Doxepin—CHRM2—central nervous system—malignant glioma	0.00118	0.00496	CbGeAlD
Doxepin—Tremor—Carmustine—malignant glioma	0.00118	0.00457	CcSEcCtD
Doxepin—KCNH2—medulla oblongata—malignant glioma	0.00118	0.00496	CbGeAlD
Doxepin—Back pain—Temozolomide—malignant glioma	0.00118	0.00456	CcSEcCtD
Doxepin—Anaemia—Carmustine—malignant glioma	0.00116	0.00451	CcSEcCtD
Doxepin—ADRA2C—medulla oblongata—malignant glioma	0.00116	0.00489	CbGeAlD
Doxepin—Agitation—Carmustine—malignant glioma	0.00116	0.00448	CcSEcCtD
Doxepin—Vision blurred—Temozolomide—malignant glioma	0.00115	0.00444	CcSEcCtD
Doxepin—Tremor—Temozolomide—malignant glioma	0.00114	0.00441	CcSEcCtD
Doxepin—HTR2C—central nervous system—malignant glioma	0.00114	0.00478	CbGeAlD
Doxepin—HTR2A—brainstem—malignant glioma	0.00113	0.00476	CbGeAlD
Doxepin—Ill-defined disorder—Temozolomide—malignant glioma	0.00113	0.00437	CcSEcCtD
Doxepin—Leukopenia—Carmustine—malignant glioma	0.00113	0.00436	CcSEcCtD
Doxepin—Anaemia—Temozolomide—malignant glioma	0.00112	0.00435	CcSEcCtD
Doxepin—Agitation—Temozolomide—malignant glioma	0.00112	0.00433	CcSEcCtD
Doxepin—Malaise—Temozolomide—malignant glioma	0.0011	0.00425	CcSEcCtD
Doxepin—Vertigo—Temozolomide—malignant glioma	0.00109	0.00423	CcSEcCtD
Doxepin—DRD2—midbrain—malignant glioma	0.00109	0.0046	CbGeAlD
Doxepin—HTR2A—retina—malignant glioma	0.00109	0.00459	CbGeAlD
Doxepin—Convulsion—Carmustine—malignant glioma	0.00109	0.00422	CcSEcCtD
Doxepin—Leukopenia—Temozolomide—malignant glioma	0.00109	0.00422	CcSEcCtD
Doxepin—Hypertension—Carmustine—malignant glioma	0.00109	0.00421	CcSEcCtD
Doxepin—SLC6A4—central nervous system—malignant glioma	0.00108	0.00453	CbGeAlD
Doxepin—KCNH2—midbrain—malignant glioma	0.00108	0.00453	CbGeAlD
Doxepin—Palpitations—Temozolomide—malignant glioma	0.00107	0.00416	CcSEcCtD
Doxepin—CHRM1—central nervous system—malignant glioma	0.00107	0.00452	CbGeAlD
Doxepin—Myalgia—Carmustine—malignant glioma	0.00107	0.00415	CcSEcCtD
Doxepin—Chest pain—Carmustine—malignant glioma	0.00107	0.00415	CcSEcCtD
Doxepin—Anxiety—Carmustine—malignant glioma	0.00107	0.00414	CcSEcCtD
Doxepin—HTR2B—central nervous system—malignant glioma	0.00107	0.00449	CbGeAlD
Doxepin—ADRA2C—midbrain—malignant glioma	0.00106	0.00447	CbGeAlD
Doxepin—Cough—Temozolomide—malignant glioma	0.00106	0.00411	CcSEcCtD
Doxepin—Convulsion—Temozolomide—malignant glioma	0.00105	0.00408	CcSEcCtD
Doxepin—Hypertension—Temozolomide—malignant glioma	0.00105	0.00407	CcSEcCtD
Doxepin—KCNH2—spinal cord—malignant glioma	0.00105	0.00442	CbGeAlD
Doxepin—ADRA2C—spinal cord—malignant glioma	0.00104	0.00436	CbGeAlD
Doxepin—Confusional state—Carmustine—malignant glioma	0.00104	0.00401	CcSEcCtD
Doxepin—Arthralgia—Temozolomide—malignant glioma	0.00104	0.00401	CcSEcCtD
Doxepin—Myalgia—Temozolomide—malignant glioma	0.00104	0.00401	CcSEcCtD
Doxepin—Anxiety—Temozolomide—malignant glioma	0.00103	0.004	CcSEcCtD
Doxepin—CYP2D6—brainstem—malignant glioma	0.00103	0.00433	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00103	0.00398	CcSEcCtD
Doxepin—Oedema—Carmustine—malignant glioma	0.00103	0.00398	CcSEcCtD
Doxepin—Discomfort—Temozolomide—malignant glioma	0.00102	0.00396	CcSEcCtD
Doxepin—Infection—Carmustine—malignant glioma	0.00102	0.00395	CcSEcCtD
Doxepin—Dry mouth—Temozolomide—malignant glioma	0.00101	0.00392	CcSEcCtD
Doxepin—Thrombocytopenia—Carmustine—malignant glioma	0.00101	0.0039	CcSEcCtD
Doxepin—HTR2A—telencephalon—malignant glioma	0.001	0.00422	CbGeAlD
Doxepin—Tachycardia—Carmustine—malignant glioma	0.001	0.00388	CcSEcCtD
Doxepin—Confusional state—Temozolomide—malignant glioma	0.001	0.00388	CcSEcCtD
Doxepin—Oedema—Temozolomide—malignant glioma	0.000993	0.00384	CcSEcCtD
Doxepin—Infection—Temozolomide—malignant glioma	0.000986	0.00382	CcSEcCtD
Doxepin—Anorexia—Carmustine—malignant glioma	0.000979	0.00379	CcSEcCtD
Doxepin—Nervous system disorder—Temozolomide—malignant glioma	0.000973	0.00377	CcSEcCtD
Doxepin—Thrombocytopenia—Temozolomide—malignant glioma	0.000972	0.00376	CcSEcCtD
Doxepin—Skin disorder—Temozolomide—malignant glioma	0.000964	0.00373	CcSEcCtD
Doxepin—CHRM3—central nervous system—malignant glioma	0.000961	0.00404	CbGeAlD
Doxepin—Hypotension—Carmustine—malignant glioma	0.00096	0.00372	CcSEcCtD
Doxepin—Hyperhidrosis—Temozolomide—malignant glioma	0.00096	0.00372	CcSEcCtD
Doxepin—Diphenhydramine—CYP2C18—malignant glioma	0.000958	0.0735	CrCbGaD
Doxepin—HTR1A—central nervous system—malignant glioma	0.000957	0.00403	CbGeAlD
Doxepin—SLC6A2—central nervous system—malignant glioma	0.000949	0.00399	CbGeAlD
Doxepin—Anorexia—Temozolomide—malignant glioma	0.000946	0.00367	CcSEcCtD
Doxepin—CHRM2—brain—malignant glioma	0.000936	0.00394	CbGeAlD
Doxepin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000936	0.00362	CcSEcCtD
Doxepin—Clomipramine—GSTP1—malignant glioma	0.000936	0.0718	CrCbGaD
Doxepin—HTR1A—cerebellum—malignant glioma	0.000935	0.00394	CbGeAlD
Doxepin—Insomnia—Carmustine—malignant glioma	0.000929	0.0036	CcSEcCtD
Doxepin—ADRA2A—medulla oblongata—malignant glioma	0.000927	0.0039	CbGeAlD
Doxepin—Paraesthesia—Carmustine—malignant glioma	0.000922	0.00357	CcSEcCtD
Doxepin—Dyspnoea—Carmustine—malignant glioma	0.000916	0.00355	CcSEcCtD
Doxepin—CYP2D6—telencephalon—malignant glioma	0.000914	0.00385	CbGeAlD
Doxepin—Somnolence—Carmustine—malignant glioma	0.000913	0.00354	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000904	0.0035	CcSEcCtD
Doxepin—HTR2C—brain—malignant glioma	0.000902	0.0038	CbGeAlD
Doxepin—Insomnia—Temozolomide—malignant glioma	0.000898	0.00348	CcSEcCtD
Doxepin—Decreased appetite—Carmustine—malignant glioma	0.000893	0.00346	CcSEcCtD
Doxepin—Paraesthesia—Temozolomide—malignant glioma	0.000891	0.00345	CcSEcCtD
Doxepin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000887	0.00343	CcSEcCtD
Doxepin—Dyspnoea—Temozolomide—malignant glioma	0.000885	0.00343	CcSEcCtD
Doxepin—Somnolence—Temozolomide—malignant glioma	0.000882	0.00342	CcSEcCtD
Doxepin—ADRA1A—central nervous system—malignant glioma	0.000882	0.00371	CbGeAlD
Doxepin—Constipation—Carmustine—malignant glioma	0.000878	0.0034	CcSEcCtD
Doxepin—Pain—Carmustine—malignant glioma	0.000878	0.0034	CcSEcCtD
Doxepin—Dyspepsia—Temozolomide—malignant glioma	0.000874	0.00338	CcSEcCtD
Doxepin—DRD2—central nervous system—malignant glioma	0.000864	0.00364	CbGeAlD
Doxepin—Decreased appetite—Temozolomide—malignant glioma	0.000863	0.00334	CcSEcCtD
Doxepin—ADRA1A—cerebellum—malignant glioma	0.000862	0.00363	CbGeAlD
Doxepin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000857	0.00332	CcSEcCtD
Doxepin—Fatigue—Temozolomide—malignant glioma	0.000856	0.00331	CcSEcCtD
Doxepin—SLC6A4—brain—malignant glioma	0.000855	0.0036	CbGeAlD
Doxepin—Desipramine—CYP2C18—malignant glioma	0.000853	0.0655	CrCbGaD
Doxepin—CHRM1—brain—malignant glioma	0.000852	0.00359	CbGeAlD
Doxepin—KCNH2—central nervous system—malignant glioma	0.000852	0.00358	CbGeAlD
Doxepin—Pain—Temozolomide—malignant glioma	0.000849	0.00329	CcSEcCtD
Doxepin—Constipation—Temozolomide—malignant glioma	0.000849	0.00329	CcSEcCtD
Doxepin—HTR2B—brain—malignant glioma	0.000848	0.00357	CbGeAlD
Doxepin—ADRA2A—midbrain—malignant glioma	0.000847	0.00357	CbGeAlD
Doxepin—Feeling abnormal—Carmustine—malignant glioma	0.000846	0.00328	CcSEcCtD
Doxepin—DRD2—cerebellum—malignant glioma	0.000845	0.00356	CbGeAlD
Doxepin—ADRA2C—central nervous system—malignant glioma	0.00084	0.00354	CbGeAlD
Doxepin—Gastrointestinal pain—Carmustine—malignant glioma	0.00084	0.00325	CcSEcCtD
Doxepin—KCNH2—cerebellum—malignant glioma	0.000832	0.0035	CbGeAlD
Doxepin—ADRA2A—spinal cord—malignant glioma	0.000827	0.00348	CbGeAlD
Doxepin—ADRA2C—cerebellum—malignant glioma	0.000821	0.00346	CbGeAlD
Doxepin—Feeling abnormal—Temozolomide—malignant glioma	0.000818	0.00317	CcSEcCtD
Doxepin—Abdominal pain—Carmustine—malignant glioma	0.000812	0.00315	CcSEcCtD
Doxepin—Body temperature increased—Carmustine—malignant glioma	0.000812	0.00315	CcSEcCtD
Doxepin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000812	0.00314	CcSEcCtD
Doxepin—ABCB1—embryo—malignant glioma	0.000808	0.0034	CbGeAlD
Doxepin—Urticaria—Temozolomide—malignant glioma	0.000788	0.00305	CcSEcCtD
Doxepin—HTR2A—medulla oblongata—malignant glioma	0.000788	0.00332	CbGeAlD
Doxepin—Abdominal pain—Temozolomide—malignant glioma	0.000785	0.00304	CcSEcCtD
Doxepin—Body temperature increased—Temozolomide—malignant glioma	0.000785	0.00304	CcSEcCtD
Doxepin—CHRM3—brain—malignant glioma	0.000763	0.00321	CbGeAlD
Doxepin—HTR1A—brain—malignant glioma	0.000759	0.0032	CbGeAlD
Doxepin—Hypersensitivity—Carmustine—malignant glioma	0.000757	0.00293	CcSEcCtD
Doxepin—SLC6A2—brain—malignant glioma	0.000753	0.00317	CbGeAlD
Doxepin—Asthenia—Carmustine—malignant glioma	0.000737	0.00285	CcSEcCtD
Doxepin—Hypersensitivity—Temozolomide—malignant glioma	0.000731	0.00283	CcSEcCtD
Doxepin—Imipramine—CYP2C18—malignant glioma	0.000723	0.0555	CrCbGaD
Doxepin—HTR2A—midbrain—malignant glioma	0.00072	0.00303	CbGeAlD
Doxepin—ABCB1—retina—malignant glioma	0.000715	0.00301	CbGeAlD
Doxepin—Asthenia—Temozolomide—malignant glioma	0.000712	0.00276	CcSEcCtD
Doxepin—Diphenhydramine—CYP2B6—malignant glioma	0.000711	0.0546	CrCbGaD
Doxepin—HTR2A—spinal cord—malignant glioma	0.000703	0.00296	CbGeAlD
Doxepin—Diarrhoea—Carmustine—malignant glioma	0.000703	0.00272	CcSEcCtD
Doxepin—Pruritus—Temozolomide—malignant glioma	0.000702	0.00272	CcSEcCtD
Doxepin—ADRA1A—brain—malignant glioma	0.0007	0.00295	CbGeAlD
Doxepin—Promethazine—CYP2B6—malignant glioma	0.000697	0.0535	CrCbGaD
Doxepin—DRD2—brain—malignant glioma	0.000686	0.00289	CbGeAlD
Doxepin—HRH1—central nervous system—malignant glioma	0.000683	0.00287	CbGeAlD
Doxepin—Dizziness—Carmustine—malignant glioma	0.000679	0.00263	CcSEcCtD
Doxepin—Diarrhoea—Temozolomide—malignant glioma	0.000679	0.00263	CcSEcCtD
Doxepin—KCNH2—brain—malignant glioma	0.000676	0.00285	CbGeAlD
Doxepin—Orphenadrine—CYP2B6—malignant glioma	0.000672	0.0516	CrCbGaD
Doxepin—ADRA2A—central nervous system—malignant glioma	0.000671	0.00282	CbGeAlD
Doxepin—ADRA2C—brain—malignant glioma	0.000667	0.00281	CbGeAlD
Doxepin—ABCB1—telencephalon—malignant glioma	0.000657	0.00277	CbGeAlD
Doxepin—Dizziness—Temozolomide—malignant glioma	0.000656	0.00254	CcSEcCtD
Doxepin—ADRA2A—cerebellum—malignant glioma	0.000655	0.00276	CbGeAlD
Doxepin—Vomiting—Carmustine—malignant glioma	0.000653	0.00253	CcSEcCtD
Doxepin—Rash—Carmustine—malignant glioma	0.000648	0.00251	CcSEcCtD
Doxepin—Dermatitis—Carmustine—malignant glioma	0.000647	0.00251	CcSEcCtD
Doxepin—Headache—Carmustine—malignant glioma	0.000643	0.00249	CcSEcCtD
Doxepin—Desipramine—CYP2B6—malignant glioma	0.000633	0.0486	CrCbGaD
Doxepin—Vomiting—Temozolomide—malignant glioma	0.000631	0.00244	CcSEcCtD
Doxepin—Rash—Temozolomide—malignant glioma	0.000626	0.00242	CcSEcCtD
Doxepin—Dermatitis—Temozolomide—malignant glioma	0.000625	0.00242	CcSEcCtD
Doxepin—Headache—Temozolomide—malignant glioma	0.000622	0.00241	CcSEcCtD
Doxepin—Trimipramine—SLC6A3—malignant glioma	0.000617	0.0474	CrCbGaD
Doxepin—Nausea—Carmustine—malignant glioma	0.00061	0.00236	CcSEcCtD
Doxepin—Nausea—Temozolomide—malignant glioma	0.00059	0.00228	CcSEcCtD
Doxepin—HTR2A—central nervous system—malignant glioma	0.00057	0.0024	CbGeAlD
Doxepin—HTR2A—cerebellum—malignant glioma	0.000557	0.00235	CbGeAlD
Doxepin—HRH1—brain—malignant glioma	0.000542	0.00228	CbGeAlD
Doxepin—Desipramine—SLC6A3—malignant glioma	0.000539	0.0414	CrCbGaD
Doxepin—Imipramine—CYP2B6—malignant glioma	0.000537	0.0412	CrCbGaD
Doxepin—Amitriptyline—CYP2B6—malignant glioma	0.000534	0.041	CrCbGaD
Doxepin—ADRA2A—brain—malignant glioma	0.000532	0.00224	CbGeAlD
Doxepin—CYP3A4—central nervous system—malignant glioma	0.000528	0.00222	CbGeAlD
Doxepin—CYP2D6—central nervous system—malignant glioma	0.000519	0.00219	CbGeAlD
Doxepin—ABCB1—medulla oblongata—malignant glioma	0.000516	0.00217	CbGeAlD
Doxepin—CYP2D6—cerebellum—malignant glioma	0.000508	0.00214	CbGeAlD
Doxepin—Nortriptyline—PTGS1—malignant glioma	0.000506	0.0388	CrCbGaD
Doxepin—ABCB1—midbrain—malignant glioma	0.000472	0.00199	CbGeAlD
Doxepin—Diphenhydramine—PTGS1—malignant glioma	0.000468	0.0359	CrCbGaD
Doxepin—ABCB1—spinal cord—malignant glioma	0.000461	0.00194	CbGeAlD
Doxepin—Imipramine—SLC6A3—malignant glioma	0.000458	0.0351	CrCbGaD
Doxepin—HTR2A—brain—malignant glioma	0.000453	0.00191	CbGeAlD
Doxepin—CYP2D6—brain—malignant glioma	0.000412	0.00174	CbGeAlD
Doxepin—ABCB1—central nervous system—malignant glioma	0.000374	0.00157	CbGeAlD
Doxepin—ABCB1—cerebellum—malignant glioma	0.000365	0.00154	CbGeAlD
Doxepin—ABCB1—brain—malignant glioma	0.000297	0.00125	CbGeAlD
Doxepin—CYP2C19—Metabolism—PPARG—malignant glioma	1.04e-05	3.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.04e-05	3.76e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.04e-05	3.75e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.03e-05	3.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	3.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	3.72e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—malignant glioma	1.03e-05	3.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	3.71e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—malignant glioma	1.02e-05	3.7e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—malignant glioma	1.02e-05	3.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—malignant glioma	1.02e-05	3.7e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTEN—malignant glioma	1.02e-05	3.69e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—malignant glioma	1.02e-05	3.68e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KRAS—malignant glioma	1.02e-05	3.67e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.01e-05	3.66e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—malignant glioma	1.01e-05	3.66e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.01e-05	3.66e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.01e-05	3.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTEN—malignant glioma	1.01e-05	3.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.01e-05	3.64e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KRAS—malignant glioma	1.01e-05	3.64e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1e-05	3.63e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1e-05	3.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—malignant glioma	1e-05	3.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—malignant glioma	1e-05	3.62e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1e-05	3.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1e-05	3.61e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	9.98e-06	3.6e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	9.96e-06	3.6e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—malignant glioma	9.95e-06	3.59e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—malignant glioma	9.94e-06	3.59e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CG—malignant glioma	9.93e-06	3.59e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	9.91e-06	3.58e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—malignant glioma	9.9e-06	3.58e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	9.9e-06	3.58e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	9.88e-06	3.57e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—malignant glioma	9.87e-06	3.57e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—malignant glioma	9.86e-06	3.56e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—malignant glioma	9.85e-06	3.56e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CG—malignant glioma	9.85e-06	3.56e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—malignant glioma	9.84e-06	3.55e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—malignant glioma	9.82e-06	3.55e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—malignant glioma	9.81e-06	3.54e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—malignant glioma	9.79e-06	3.54e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	9.78e-06	3.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—malignant glioma	9.77e-06	3.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	9.77e-06	3.53e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	9.76e-06	3.53e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—malignant glioma	9.7e-06	3.5e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—malignant glioma	9.69e-06	3.5e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—malignant glioma	9.68e-06	3.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—malignant glioma	9.67e-06	3.49e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	9.65e-06	3.49e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—malignant glioma	9.65e-06	3.49e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—malignant glioma	9.65e-06	3.49e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—malignant glioma	9.6e-06	3.47e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—malignant glioma	9.59e-06	3.46e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—malignant glioma	9.55e-06	3.45e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—malignant glioma	9.52e-06	3.44e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—malignant glioma	9.5e-06	3.43e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CD—malignant glioma	9.49e-06	3.43e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—malignant glioma	9.48e-06	3.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—malignant glioma	9.46e-06	3.42e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—malignant glioma	9.43e-06	3.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	9.38e-06	3.39e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	9.38e-06	3.39e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	9.34e-06	3.37e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—malignant glioma	9.34e-06	3.37e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—malignant glioma	9.33e-06	3.37e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—malignant glioma	9.31e-06	3.36e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—malignant glioma	9.29e-06	3.36e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—malignant glioma	9.28e-06	3.35e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—malignant glioma	9.28e-06	3.35e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CD—malignant glioma	9.27e-06	3.35e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—malignant glioma	9.26e-06	3.35e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—malignant glioma	9.26e-06	3.34e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—malignant glioma	9.25e-06	3.34e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	9.24e-06	3.34e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—malignant glioma	9.24e-06	3.34e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—malignant glioma	9.24e-06	3.34e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	9.24e-06	3.34e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—malignant glioma	9.23e-06	3.33e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—malignant glioma	9.2e-06	3.32e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—malignant glioma	9.2e-06	3.32e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—malignant glioma	9.16e-06	3.31e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—malignant glioma	9.14e-06	3.3e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—malignant glioma	9.14e-06	3.3e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—malignant glioma	9.11e-06	3.29e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—malignant glioma	9.08e-06	3.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	9.07e-06	3.28e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—malignant glioma	9.05e-06	3.27e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—malignant glioma	9.04e-06	3.27e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—malignant glioma	9.04e-06	3.26e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—malignant glioma	9.03e-06	3.26e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—malignant glioma	9e-06	3.25e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—malignant glioma	8.98e-06	3.25e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—malignant glioma	8.97e-06	3.24e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—malignant glioma	8.97e-06	3.24e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—malignant glioma	8.94e-06	3.23e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—malignant glioma	8.92e-06	3.22e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—malignant glioma	8.88e-06	3.21e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—malignant glioma	8.88e-06	3.21e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	8.86e-06	3.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.83e-06	3.19e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—malignant glioma	8.77e-06	3.17e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NCOR1—malignant glioma	8.75e-06	3.16e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CD—malignant glioma	8.73e-06	3.15e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—malignant glioma	8.73e-06	3.15e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	8.69e-06	3.14e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—malignant glioma	8.68e-06	3.14e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CD—malignant glioma	8.66e-06	3.13e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—malignant glioma	8.63e-06	3.12e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—malignant glioma	8.54e-06	3.09e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—malignant glioma	8.51e-06	3.08e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—malignant glioma	8.5e-06	3.07e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—malignant glioma	8.49e-06	3.07e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—malignant glioma	8.44e-06	3.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—malignant glioma	8.44e-06	3.05e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—malignant glioma	8.43e-06	3.05e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—malignant glioma	8.41e-06	3.04e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—malignant glioma	8.41e-06	3.04e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—malignant glioma	8.38e-06	3.03e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—malignant glioma	8.36e-06	3.02e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—malignant glioma	8.36e-06	3.02e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—malignant glioma	8.33e-06	3.01e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—malignant glioma	8.31e-06	3e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—malignant glioma	8.31e-06	3e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—malignant glioma	8.3e-06	3e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—malignant glioma	8.28e-06	2.99e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CB—malignant glioma	8.27e-06	2.99e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—malignant glioma	8.25e-06	2.98e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—malignant glioma	8.24e-06	2.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	8.23e-06	2.97e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—malignant glioma	8.23e-06	2.97e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—malignant glioma	8.22e-06	2.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	8.2e-06	2.96e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—malignant glioma	8.2e-06	2.96e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—malignant glioma	8.2e-06	2.96e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—malignant glioma	8.15e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—malignant glioma	8.12e-06	2.93e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—malignant glioma	8.12e-06	2.93e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CB—malignant glioma	8.08e-06	2.92e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—malignant glioma	8e-06	2.89e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—malignant glioma	7.98e-06	2.88e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—malignant glioma	7.89e-06	2.85e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—malignant glioma	7.85e-06	2.84e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	7.85e-06	2.83e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—malignant glioma	7.83e-06	2.83e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—malignant glioma	7.76e-06	2.8e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—malignant glioma	7.71e-06	2.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—malignant glioma	7.69e-06	2.78e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—malignant glioma	7.67e-06	2.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—malignant glioma	7.66e-06	2.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—malignant glioma	7.64e-06	2.76e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—malignant glioma	7.63e-06	2.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	7.62e-06	2.75e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.61e-06	2.75e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—malignant glioma	7.59e-06	2.74e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	7.57e-06	2.74e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—malignant glioma	7.57e-06	2.73e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—malignant glioma	7.55e-06	2.73e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—malignant glioma	7.55e-06	2.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—malignant glioma	7.55e-06	2.73e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CB—malignant glioma	7.54e-06	2.73e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—malignant glioma	7.54e-06	2.72e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—malignant glioma	7.54e-06	2.72e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	7.54e-06	2.72e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—malignant glioma	7.52e-06	2.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—malignant glioma	7.5e-06	2.71e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—malignant glioma	7.48e-06	2.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—malignant glioma	7.48e-06	2.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—malignant glioma	7.4e-06	2.67e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CD—malignant glioma	7.4e-06	2.67e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—malignant glioma	7.38e-06	2.67e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	7.33e-06	2.65e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—malignant glioma	7.33e-06	2.65e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—malignant glioma	7.29e-06	2.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—malignant glioma	7.24e-06	2.62e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	7.21e-06	2.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—malignant glioma	7.16e-06	2.59e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—malignant glioma	7.15e-06	2.58e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—malignant glioma	7.13e-06	2.58e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—malignant glioma	7.12e-06	2.57e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—malignant glioma	7.12e-06	2.57e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—malignant glioma	7.11e-06	2.57e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—malignant glioma	7.1e-06	2.57e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—malignant glioma	7.09e-06	2.56e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—malignant glioma	7.08e-06	2.56e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—malignant glioma	7.06e-06	2.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—malignant glioma	7.01e-06	2.53e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—malignant glioma	6.99e-06	2.53e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—malignant glioma	6.98e-06	2.52e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—malignant glioma	6.98e-06	2.52e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—malignant glioma	6.97e-06	2.52e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—malignant glioma	6.86e-06	2.48e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—malignant glioma	6.65e-06	2.4e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—malignant glioma	6.58e-06	2.38e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	6.54e-06	2.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—malignant glioma	6.53e-06	2.36e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—malignant glioma	6.52e-06	2.36e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	6.51e-06	2.35e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.49e-06	2.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	6.49e-06	2.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—malignant glioma	6.48e-06	2.34e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CB—malignant glioma	6.45e-06	2.33e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—malignant glioma	6.43e-06	2.32e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	6.42e-06	2.32e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—malignant glioma	6.41e-06	2.32e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	6.41e-06	2.31e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—malignant glioma	6.39e-06	2.31e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—malignant glioma	6.34e-06	2.29e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—malignant glioma	6.33e-06	2.29e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—malignant glioma	6.32e-06	2.28e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—malignant glioma	6.3e-06	2.27e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—malignant glioma	6.28e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—malignant glioma	6.27e-06	2.26e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—malignant glioma	6.22e-06	2.25e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—malignant glioma	6.2e-06	2.24e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—malignant glioma	6.19e-06	2.24e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.16e-06	2.22e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—malignant glioma	5.99e-06	2.16e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	5.95e-06	2.15e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—malignant glioma	5.89e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—malignant glioma	5.82e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—malignant glioma	5.76e-06	2.08e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.71e-06	2.06e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—malignant glioma	5.57e-06	2.01e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—malignant glioma	5.43e-06	1.96e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—malignant glioma	5.35e-06	1.93e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—malignant glioma	5.33e-06	1.93e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—malignant glioma	5.32e-06	1.92e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—malignant glioma	5.3e-06	1.91e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—malignant glioma	5.25e-06	1.9e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.23e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—malignant glioma	5.04e-06	1.82e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.98e-06	1.8e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—malignant glioma	4.93e-06	1.78e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—malignant glioma	4.92e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.86e-06	1.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.64e-06	1.68e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.6e-06	1.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—malignant glioma	4.3e-06	1.55e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—malignant glioma	4.12e-06	1.49e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—malignant glioma	4.02e-06	1.45e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.93e-06	1.42e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—malignant glioma	3.79e-06	1.37e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—malignant glioma	3.76e-06	1.36e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—malignant glioma	3.21e-06	1.16e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.03e-06	1.1e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—malignant glioma	2.48e-06	8.95e-06	CbGpPWpGaD
